Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours
Ciro Celsa(Hammersmith Hospital), Fable Zustovich, Marilena Di Napoli(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Raffaele Giusti(CTO Andrea Alesini), Amit G. Singal(The University of Texas Southwestern Medical Center), Celina Ang(Mount Sinai Hospital), Pei‐Chang Lee(National Yang Ming Chiao Tung University), Francesca Salani(Scuola Superiore Sant'Anna), Kornelius Schulze(Universität Hamburg), Antonio D’Alessio(Imperial College London), Giuseppe Cabibbo(University of Palermo), Alessandro Parisi(Marche Polytechnic University), Johann von Felden(Universität Hamburg), Naoshi Nishida(Kindai University), Masatoshi Kudo(Kindai University), Caterina Vivaldi(Scuola Superiore Sant'Anna), Paul El Tomb(University of Oklahoma Medical Center), Susanna V. Ulahannan(National Institutes of Health), Bernhard Scheiner(Medical University of Vienna), Anwaar Saeed(University of Pittsburgh), Claudia Angela Maria Fulgenzi(Università Campus Bio-Medico), Samuel Phen(The University of Texas Southwestern Medical Center), Elena Verzoni(Fondazione IRCCS Istituto Nazionale dei Tumori), Anjana Pillai(Azienda Ospedaliera Universitaria Pisana), Robert Thimme(University of Freiburg), Matthias Pinter(Harvard University), Thomas U. Marron(Icahn School of Medicine at Mount Sinai), Gianluca Masi(Ospedale di Livorno), Ernesto Rossi(Agostino Gemelli University Polyclinic), Brooke Wietharn(The University of Kansas Cancer Center), Lorenza Rimassa(Humanitas University), Giulia Francesca Manfredi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Hong Jae Chon(CHA University), Peter R. Galle, Yi‐Hsiang Huang(National Yang Ming Chiao Tung University), Martin Schönlein(Universität Hamburg), Paola Ermacora(Presidio Ospedaliero), Francesco Verderame(Ospedale Vincenzo Cervello), Antonello Veccia(Ospedale Santa Chiara), Bernardo Stefanini(University of Bologna), Natascha Roehlen(Inserm), Arndt Vogel(Medizinische Hochschule Hannover), Annamaria Catino(Istituto Tumori Bari), Anuhya Gampa(University of Chicago), Henning Wege(Universität Hamburg), Giuseppe Aprile(Ospedale San Bortolo), Wei‐Fan Hsu(China Medical University), Lorenzo Antonuzzo(University of Florence), Pamela Francesca Guglielmini(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), Jaekyung Cheon(CHA University Bundang Medical Center)
Cited by 62
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
|Hepatology|2023|1.6k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k